Hefei WeHexa : A Hardcore Player in the Synthetic Biology Arena, Reconstructing Industrial New Quality Productive Forces with CAS-Grade Technology
Release time: 2026-09-04
As synthetic biology becomes the core engine of the third biotechnology revolution, biomanufacturing is emerging at the forefront of new quality productive forces. Backed by 30+ years of accumulated innovation in biomanufacturing,Hefei WeHexa Biotechnology Co., Ltd.makes its powerful debut — rooted in top-tier Chinese Academy of Sciences (CAS) technology, committed to becoming a leader in functional ingredient innovation, and reshaping the future of industry through biotechnology.
CAS Technology Heritage, Cross-Disciplinary Integration as the Breakthrough
Our technological strength stems from deep empowerment by a world-class research platform. As a technology spin-off of the Chinese Academy of Sciences, we draw on the engineering expertise of the nuclear fusion mega-science program, seamlessly integrating ion-beam microbial breeding with synthetic biology to achieve a technological leap from microbial design to gene synthesis.
With plasma-based breeding technology as the key breakthrough, we have built a comprehensive synthetic biology technology matrix and advanced along a dual-driven path of "hardcore R&D + industrial transformation" — bringing cutting-edge bio-innovation out of the laboratory and into real-world industrial applications, thereby cementing the core technological foundation for the R&D and production of functional ingredients.
Top-Tier R&D Team, 60+ Patents Forging a Technical Moat
Our scientific strength is underpinned by a senior team with deep domain expertise and sustained intellectual-property deployment. Weihe Hexagon brings together seasoned experts in synthetic biology, microbial engineering, and biomanufacturing who have been deeply involved in core technology development, collectively securing 60+ granted invention patents spanning the entire process — from strain construction to separation and purification — for core products including L-fucose, sialic acid, and GABA.
From high-yield strain engineering to high-purity ingredient extraction, every patent stands as tangible proof of technical strength, and every innovation reinforces the technological moat in the functional ingredient track, keeping us at the internationally leading level.
Full-Chain Value Loop, Technology Landing to Empower Industry
We firmly believe that outstanding technology must ultimately land in industry to create value. Hefei WeHexa has established a complete value loop — core R&D, pilot-scale validation, small-batch production, industrial-scale manufacturing, and sales & service — achieving end-to-end connectivity from technological innovation to market deployment.
Our current core products include L-fucose, γ-aminobutyric acid (GABA), 5-aminolevulinic acid, and ectoine. We have forged partnerships with multiple renowned companies, covering sectors such as infant formula, functional foods, cosmeceuticals, and bio-agriculture — empowering biomanufacturing with synthetic biology and injecting hardcore bio-tech momentum into the upgrading of diverse industries.
The era of synthetic biology has arrived. Rooted in technology and empowered by our team, Hefei WeHexa is steadily advancing along the functional ingredient track.
In our next article, we will unveil the core product matrix, showcasing the boundless possibilities biotechnology brings to functional ingredients!
✨Hefei WeHexa Biotechnology Co., Ltd
